Literature DB >> 33414749

Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study.

Valentina Elisabetta Di Mattei1,2, Gaia Perego3, Paola Maria Vittoria Rancoita4,5, Paola Taranto1, Letizia Carnelli1, Giorgia Mangili6, Veronica Sarais6, Alice Bergamini6, Massimo Candiani5,6.   

Abstract

OBJECTIVE: Gonadotoxicity is considered one of the most distressing side effects of cancer treatment. Although fertility preservation can be a valid solution, it also involves a challenging process. A clear understanding of the features of women who decide to pursue fertility preservation after cancer diagnosis is missing. The purpose of the present study was therefore to analyze the personality profile of female patients referred to oncofertility prior to gonadotoxic treatment.
METHODS: Fifty-two female cancer patients took part in the study. The Temperament and Character Inventory-Revised (TCI-R), the Response Evaluation Measure-71 (REM-71), the Beck Depression Inventory (BDI-II), and the State-Trait Anxiety Inventory-Y Form (STAI-Y) were administered to examine personality characteristics, defense mechanisms, depression and anxiety symptoms.
RESULTS: Compared with reference data of the Italian population, our sample reported significantly lower scores in Harm Avoidance and trait anxiety, and significantly higher levels of mature defense mechanisms. Most of the patients reported low scores in immature defense mechanisms, depression, and trait anxiety, and medium scores in state anxiety.
CONCLUSIONS: Our findings suggest that these women display functional personality traits and defensive style, in association with low levels of depression and trait anxiety. These features may enable a proactive attitude to cancer and the ability to make long-term plans. This may favor psychological adjustment to cancer and a projection toward the future.
Copyright © 2020 Di Mattei, Perego, Rancoita, Taranto, Carnelli, Mangili, Sarais, Bergamini and Candiani.

Entities:  

Keywords:  REM-71; TCI-R; anxiety; defense mechanisms; depression; fertility preservation; oncology; personality

Year:  2020        PMID: 33414749      PMCID: PMC7783324          DOI: 10.3389/fpsyg.2020.608651

Source DB:  PubMed          Journal:  Front Psychol        ISSN: 1664-1078


  42 in total

1.  Personality variables as predictors of early non-metastatic colorectal cancer patients' psychological distress and health-related quality of life: a one-year prospective study.

Authors:  Thomas Hyphantis; Vassiliki Paika; Augoustina Almyroudi; Eleftherios O Kampletsas; Nicholas Pavlidis
Journal:  J Psychosom Res       Date:  2010-12-16       Impact factor: 3.006

2.  Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles.

Authors:  Giovanni Martinotti; Laura Mandelli; Marco Di Nicola; Alessandro Serretti; Andrea Fossati; Serena Borroni; C Robert Cloninger; Luigi Janiri
Journal:  Compr Psychiatry       Date:  2008-06-03       Impact factor: 3.735

3.  A systematic review of patient oncofertility support needs in reproductive cancer patients aged 14 to 45 years of age.

Authors:  S Logan; J Perz; J M Ussher; M Peate; A Anazodo
Journal:  Psychooncology       Date:  2017-09-13       Impact factor: 3.894

4.  Defense mechanisms in cancer patients: a systematic review.

Authors:  Mariagrazia Di Giuseppe; Rebecca Ciacchini; Tommaso Micheloni; Ilaria Bertolucci; Laura Marchi; Ciro Conversano
Journal:  J Psychosom Res       Date:  2018-10-29       Impact factor: 3.006

5.  Cancer survival probability as a function of ego defense (adaptive) mechanisms versus depressive symptoms.

Authors:  Thomas P Beresford; Julie Alfers; Laura Mangum; Lori Clapp; Brandon Martin
Journal:  Psychosomatics       Date:  2006 May-Jun       Impact factor: 2.386

6.  It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer--an Australian fertility decision aid collaborative group study.

Authors:  Michelle Peate; Bettina Meiser; Michael Friedlander; Helen Zorbas; Susan Rovelli; Ursula Sansom-Daly; Jennifer Sangster; Dusan Hadzi-Pavlovic; Martha Hickey
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

7.  [Gestational Trophoblastic Disease: psychological impact and the role of defence mechanisms during illness and follow-up].

Authors:  Valentina Elisabetta Di Mattei; Martina Mazzetti; Letizia Carnelli; Martina Bernardi; Rossella Di Pierro; Alice Bergamini; Veronica Giorgione; Giorgia Mangili
Journal:  Recenti Prog Med       Date:  2015-12

8.  Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study.

Authors:  Thomas Hyphantis; Augoustina Almyroudi; Vassiliki Paika; Lesley F Degner; André F Carvalho; Nicholas Pavlidis
Journal:  Psychooncology       Date:  2013-05-27       Impact factor: 3.894

9.  Test-retest reliabilities of State-Trait Anxiety Inventory in a stressful social analogue situation.

Authors:  W R Rule; M D Traver
Journal:  J Pers Assess       Date:  1983-06

10.  The nature and correlates of change in depressive symptoms with cancer diagnosis: reaction and adaptation.

Authors:  Frank J Infurna; Denis Gerstorf; Nilam Ram
Journal:  Psychol Aging       Date:  2012-09-17
View more
  2 in total

1.  Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients.

Authors:  Valentina Elisabetta Di Mattei; Gaia Perego; Paola Taranto; Paola M V Rancoita; Mariangela Maglione; Lisa Notarianni; Giorgia Mangili; Alice Bergamini; Raffaella Cioffi; Enrico Papaleo; Massimo Candiani
Journal:  Front Psychol       Date:  2021-12-16

Review 2.  Oncofertility and COVID-19: At the Crossroads between Two Time-Sensitive Fields.

Authors:  Valentin Nicolae Varlas; Roxana Georgiana Borș; Anca Lucia Pop; Bogdana Adriana Năsui; Nicolae Bacalbasa; Roxana Bohîlțea; Radu Vlădăreanu; Corina Manolea
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.